Pharmaceutical Disease Producing Factories Administered Dangerous Isoniazide And Sulfadiazide To Spread Tuberculosis

“Pharmaceuticals Companies Make Business With Intentionally Created Diseases In Africa”- Professor Johan Van Dongen.

Johan 2

Professor Johan Van Dongen, the former Micro-Surgeon.

According to the German scientist Wolff Geisler, thousands of Aids patients affected with tuberculosis in Africa, are not caused by the HIV virus. In my opinion he is right, because the increase of the number of tuberculosis patients in Africa, is a result of intended spread of the disease through dangerous medicines like Isoniazid and Sulfadianozide , given to Africans in tuberculosis clinics in African countries, such as Burundi, the former Belgian Congo, Uganda and Zambia. Instead of curing, the two mentioned medicines rather cause a tremendous acceleration of HIV infections amongst African people.

The WHO/IUATLD Working Group And Wolff Geisler

In 1989, the WHO/IUATLD working group declared in the “Bulletin International Union Tuberculosis Lung Disease” that HIV in TB-hospitals could have been spread as a result of unhygienic anti-tuberculosis injections, but as a former micro-surgeon, I, Johan van Dongen challenge them to prove that statement.

Again according to Wolff Geisler, remarkably horrendous numbers of HIV-infections originate only from US American or British financed and managed hospitals in the respectively mentioned countries. For instance in hospitals in Kitgum and Kagando in Uganda (where there was no recognizable USA or British finance), 10% of the TB patients, normally an average of 15% of the total population were HIV infected.

Aids Causing Factories

According to the World Health Organization, in Africa 17-55% of TB patients have HIV-antibodies. The WHO expert Slutkin mentioned 30-60% in some of the developing countries, a clear sign of intentional infection of tuberculosis patients in Zambia with HIV. The same evidence was provided by the same expert in the Chinkala Hospital, TB patients Mazubuku. 23% of the TB patients in the middle of 1987 were also infected with HIV.

Six months later, the virus was located in 50% of patients within the same hospital, after administering Isoniazid and Sulfadiazide. The same figures slightly increased in 58% of TB patients in Ndola, and in 60% of TB patients in the University Teaching Hospital in Lusaka, Zambia.

In the Makalala Sanatorium in Kinshasa, Zaire, 33% of TB patients had HIV antibodies (among the staff: 4-8%), and in Chinkankata 36%. In Malawi, 50-66% of TB patients also had HIV antibodies. In the TB clinic, Centre Anti Tuberculeux de Bujumbura in Burundi, 55% of TB patients were HIV-infected in 1986, and in the Mwanza region of Tanzania, 25% of TB patients had HIV-antibodies. Moreover, the patients were treated with forbidden drugs, because in New York, 1972, about 21 people who were taking intravenous agents had succumbed to inexplicable tuberculosis before 1972.

Already written in a previous article, in contrast, patient with a cellular deficiency hypersensitivity following the polio- and cowpox vaccinations, are particularly prone to certain bacterial, viral and protozoal infections caused by Mycobacterium tuberculosis TB. And then the pharmaceutical disease producing factories appear by using deadly toxic agents such as Isoniazid, produced by Teva Netherlands BV (Holland, and Sulfadiazide, produced by Pfizer in Germany.

What Is Tuberculosis?

Tuberculosis is a chronically infectious disease which generally affects the lungs. The causing agent, tubercle bacilli, is mostly passed on from person to person through coughing of droplets from the respiratory tract (lungs), and can also be transmitted onto the skin, eyes of persons in the immediate vicinity. Tubercles also can penetrate the body through drinking.

A striking phenomenon! Side Effects Of Isoniazid And Sulfadiozanide.

Hospitals, including Mbare Hospital in Harare, were suddenly full of tuberculosis patients and the people were suffering from venereal diseases at the same time, as a side effect consequence, because Isoniazid and Sulfadiazide made them susceptible for these. It is obvious that Isoniazid and Sulfadiazide are the cause of these venereal diseases because it appears in almost all infected children under the age of ten.

As described before, in Africa tuberculosis and HIV go hand in hand, but the mass spread of tuberculosis infections in Africans with Aids is not caused by HIV-infection at all. The increase in the number of African TB patients is the result of intended spread of special tuberculosis agents, and patients treated with Sulfadiozanide and Isoniazid at the end caught Aids!

Disease Factories Using Isoniazid And Sulfadiozanide

The two medicines, Isoniazid and Sulfadiazide, shouldn’t have been used as medications against TB and most certainly not in Aids patients. Only the long list of side effects gives you the shivers. Therefore we will describe a list with side effects causing a huge amount of invented new diseases in order to sell more medicines against these side effects……

TB 3

Tuberculosis patients in a hospital.

Side Effects Caused By Isoniazid And Sulfadiazide There we go! And We Are starting With:

“Anxiety, blurred vision, changes in menstrual periods, chills, cold sweats, coma, confusion, cool, pale skin, decreased sexual ability in males, depression, dizziness, ‘dry’ puffy skin, fast heartbeat, feeling cold, headache, increased hunger, nausea, nervousness, nightmares, seizures, shakiness, slurred speech, swelling of front part of the neck, unusual tiredness or weakness and last but not least: weight gain.”

There You Have It. And If You Think This List Of Side Effects Is Completed, Not at all! There Is More: Let’s continue:

“Abdominal or stomach pain, back- leg- or stomach pains, ‘black’ tarry stools, bleeding gums, bleeding under the skin, blindness or vision changes, “blistering, peeling, or loosening” of the skin, bloating, blood in the urine or stools, “bluish-colored lips, fingernails or palms”, burning of the face or mouth, –burning, crawling, itching, numbness, painful, prickling, “pins and needles”, or tingling feelings–, chest pain, cloudy urine, clumsiness or unsteadiness.

Constipation, continuing ringing or buzzing or other unexplained noise in the ears, cough or hoarseness, cracks in the skin, darkened urine, decrease in the amount of urine, diarrhea, difficulty with breathing, difficulty with moving, dizziness or lightheadedness, feeling of discomfort, fever with or without chills, general body swelling, general feeling of tiredness or weakness, headache, hearing loss.

Indigestion, itching- joint or muscle pain, light-colored stools, loss of appetite and weight, loss of heat from the body, lower back or side pain, muscle pain or stiffness, nosebleeds, not able to pass urine, pain or burning while urinating, painful or difficult urination, “pains in the stomach side or abdomen and possibly radiating to the back”, pale skin, pinpoint red or purple spots on the skin, rapid heart rate, rash, “red skin lesions often with a purple center.”

Red irritated eyes, red swollen skin, redness of the white part of the eyes, scaly skin, “seeing, hearing, or feeling things that are not there”, seizures, shakiness and unsteady walk, shortness of breath, sore throat, soreness of the muscles, sores, ulcers, or white spots on the lips or in the mouth, sudden decrease in amount of urine, swelling around the eyes.

“Swelling of the face, hands, legs, and feet”, swelling or inflammation of the mouth, swollen lymph glands, swollen or painful glands, tightness in the chest, “unsteadiness, trembling, or other problems with muscle control or coordination”, unusual bleeding or bruising, upper right abdominal pain, vision changes, vomiting, weakness in the hands or feet, wheezing, yellow eyes or skin.”

“Some side effects do not need medication, because of fear, you will pay a visit to a doctor, you have to pay consultation fee, you also have to pay for the prescription and medicines and together we pay billions of dollars to the pharmaceutical industry, and  in turn they pay scientists, pharmacists and everybody else who wants to be paid in order to sell medicines for causing the above-mentioned side effects for the production of diseases.”

Pharmacists, Doctors And Scientist Paid By The Pharmaceutical Industry

Some Sulfadiazine side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects but do check with them if any of the following side effects continue, or if you are concerned about them.

And for each and every one of these checks, because of side effects you will pay a visit to a doctor, you have to pay for the consultation fee, you also will have to pay for the prescription and medicines and together we pay billions of dollars to the pharmaceutical industry and the pharmaceutical industry pay scientists, pharmacists and everybody else, who wants to be paid in order to sell medicines for causing the above-mentioned side effects for the production of diseases.

Incidence Side Effects Not known

Feeling of constant movement of self or the surroundings, hives or welts, the sensation of spinning, restlessness, and trouble with sleeping.

Healthcare Professionals Applies To Sulfadiazine: Compounding Powder, Oral Tablet Causing Hypersensitivity




Hematologic side effects include agranulocytosis (0.1%), aplastic anemia, hemolytic anemia (0.05%), hypoprothrombinemia, leukopenia, methemoglobinemia, and purpura. Hemolytic anemia occurs less often with sulfadiazine than with other sulfonamides. Aplastic anemia may be more likely in patients with poor bone marrow reserves.

Gastrointestinal Side Effects

Gastrointestinal side effects include nausea, vomiting, abdominal pain, diarrhea, anorexia, pancreatitis, and stomatitis.

Hepatic Side Effects


Psychiatric Side Effects

Psychosis associated with Sulfadiazine and Pyrimethamine therapy in patients with AIDS and CNS toxoplasmosis has been described in two separate case reports. In each case, tremulousness and disorientation developed within three days to two weeks after starting therapy, despite partial resolution of the size of the intracranial T Gondii lesions. No other obvious cause for mental status changes was found.

The delirium resolved upon discontinuation of therapy in each case and was reproducible upon re-challenged. In one case, the patient had elevated liver function tests (hepatitis panel was negative), which were reversible upon discontinuation of therapy. Psychiatric side effects include frank psychosis in patients with AIDS and CNS toxoplasmosis. Tremulousness, disorientation, and delirium have been reported.

Nervous System Side Effects

Nervous system side effects include ataxia, convulsions, hallucinations, headache, insomnia, mental depression, peripheral neuritis, tinnitus, and vertigo.

Renal Side Effects

Renal side effects include crystalluria, lupus erythematosus, periarteritis nodosa, toxic nephrosis with oliguria and anuria, and acute renal failure secondary to crystalluria or tubulointerstitial nephritis.

Genitourinary Side Effects


Genitourinary side effects include urolithiasis.

Metabolic Side Effects

Metabolic side effects have included hypoglycemia.

Endocrine side effects


If you swallow Isoniazid and Sulfadianozide or AZT as mentioned in one of our previous articles, then you are a lunatic.


  1. Tenant-Flowers M, Boyle M, Carey D, et al “Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis.” AIDS 5 (1991): 311-5
  2. Finland M, Strauss E, Peterson O “Sulfadiazine.” JAMA 251 (1984): 1467-74
  3. Robson M, Levi J, Dolberg L, Rosenfeld J “Acute tubulointerstitial nephritis following sulfadiazine therapy.” Isr J Med Sci 6 (1970): 561-
  4. Finland M, Strauss E, Peterson O “Sulfadiazine.” JAMA 116 (1941): 2641-7
  5. Goadsby P, Donaghy A, Lloyd A, Wakefield D “Acquired immunodeficiency syndrome (AIDS) and sulfadiazine-associated acute renal failure.” Ann Intern Med 107 (1987): 783-4
  6. Pisanty S, Brayer L “Erythema multiforme-like eruption due to sulfadiazine.” J Dent Med 20 (1965): 154-7
  7. Roujeau JC, Kelly JP, Naldi L, et al. “Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.” N Engl J Med 333 (1995): 1600-
  8. “Product Information. Sulfadiazine (sulfadiazine).” Eon Labs Manufacturing Inc, Laurelton, NY.
  9. Carbone L, Bendixen B, Appel G “Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome.” Am J Kidney Dis 12 (1988): 72-5
  10. Carrion-Carion C, Morales-Suarez-Varela MM, Llopis-Gonzalez A “Fatal Stevens-Johnson syndrome in an AIDS patient treated with sulfadiazine.” Ann Pharmacother 33 (1999): 379
  11. Kounis GN, Kouni SA, Chiladakis JA, Kounis NG “Comment: Mesalamine-Associated Hypersensitivity Myocarditis in Ulcerative Colitis and the Kounis Syndrome (February).” Ann Pharmacother 43 (2009): 393-4
  12. Iaccheri B, Fiore T, Papadaki T, et al. “Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review.” Clin Ther 30 (2008): 2069-74
  13. Puckett J, Cooper M, Stuart J, Wu WC, Sterchi JM “Pyrimethamine, sulfadiazine, and villous atrophy of the jejunum.” Ann Intern Med 96 (1982): 380
  14. Reboli AC, Mandler HD “Encephalopathy and psychoses associated with sulfadiazine in two patients with AIDS and CNS toxoplasmosis.” Clin Infect Dis 15 (1992): 556-7
  15. Young C “Acute encephalopathy associated with sulfadiazine in a patient with AIDS-related complex.” J Infect Dis 160 (1989): 163-4
  16. Dusseault BN, Croce KJ, Pais VM Jr “Radiographic characteristics of sulfadiazine urolithiasis.” Urology 73 (2009): 928.e5-6
  17. Crespo M, Quereda C, Pascual J, Rivera M, Clemente L, Cano T “Patterns of sulfadiazine acute nephrotoxicity.” Clin Nephrol 54 (2000): 68-72
  18. Schuler AK, Talor Z “The case: 69-year-old man, with sand in the urine. N-acetyl sulfadiazine crystals.” Kidney Int 72 (2007): 769-70
  19. Perazella MA “Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity.” Am J Med Sci 325 (2003): 349-62
  20. Marques LPJ, Madeira EPQ, Santos OR “Renal alterations induced by sulfadiazine therapy in an AIDS patients.” Clin Nephrol 42 (1994): 68-9
  21. Anibarro B, Fontela JL “Sulfadiazine-induced sialadenitis.” Ann Pharmacother 31 (1997): 59-60